[Administration of the immunomodulator gepon after tonsillectomy].
The study included 37 patients with chronic tonsillitis. Before and after tonsillectomy all the patients' humoral and cellular immunities were studied. Local thermometry and physiological test "pharynx" were made. For optimization of early postoperative period, all the tonsillectomized patients were given a domestic immunomodulator with local anti-inflammatory activity gepon. The results of gepon therapy allowed conclusion that local use of immunomodulator gepon early after bilateral tonsillectomy is justified and can be recommended for wide clinical practice.
Starosvetskiĭ
A B
AB
Pichugina
A V
AV
Kazarova
A A
AA
Ataullakhanov
R I
RI
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000293:Adolescent; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use*; D016827:CD8 Antigens / Q000187:drug effects; D002908:Chronic Disease; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000494:pharmacology / Q000627:therapeutic use*; D007694:Killer Cells, Natural / Q000187:drug effects; D008297:Male; D009504:Neutrophils / Q000187:drug effects; D009842:Oligopeptides / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000517:prevention & control*; D014068:Tonsillectomy / Q000379:methods*; D014069:Tonsillitis / Q000601:surgery*
D000276:Adjuvants, Immunologic; D000893:Anti-Inflammatory Agents; D000998:Antiviral Agents; D016827:CD8 Antigens; D007155:Immunologic Factors; D009842:Oligopeptides